Over the last few weeks, we’ve highlighted some of the top COVID-19 vaccine stocks.
And most have done incredibly well – with the exception of Gilead Sciences (GILD).
Look at BioNTech (BNTX) for example.
Just weeks ago, it and Pfizer said they’ve begun delivering doses of their experimental coronavirus vaccines for initial human testing in the United States, says CNBC. “If the vaccine proves to be safe and effective in trials, it could potentially be ready for wide U.S. distribution by...
Already a member? Login below, or click here to register now for free.